Vitalhub Corp. (TSE:VHI - Free Report) - Stock analysts at Raymond James Financial decreased their Q3 2025 EPS estimates for Vitalhub in a research report issued to clients and investors on Thursday, June 19th. Raymond James Financial analyst M. Freeman now expects that the company will post earnings of $0.00 per share for the quarter, down from their prior forecast of $0.05. Raymond James Financial has a "Outperform" rating and a $14.00 price target on the stock. The consensus estimate for Vitalhub's current full-year earnings is $0.23 per share. Raymond James Financial also issued estimates for Vitalhub's Q4 2025 earnings at $0.03 EPS and FY2025 earnings at $0.10 EPS.
VHI has been the subject of a number of other reports. National Bank Financial raised shares of Vitalhub to a "strong-buy" rating in a research report on Monday, June 9th. TD Securities raised their target price on shares of Vitalhub from C$13.00 to C$14.00 and gave the company a "buy" rating in a research note on Monday, March 31st. National Bankshares set a C$14.00 price target on shares of Vitalhub and gave the stock an "outperform" rating in a report on Tuesday, June 10th. Finally, Scotiabank increased their price objective on Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a report on Friday. Six analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of C$13.25.
View Our Latest Report on VHI
Vitalhub Price Performance
Shares of TSE VHI opened at C$11.15 on Monday. Vitalhub has a 1-year low of C$6.74 and a 1-year high of C$12.34. The business has a fifty day moving average price of C$10.60 and a 200 day moving average price of C$10.61. The stock has a market capitalization of C$603.13 million, a P/E ratio of 181.35, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26.
Insider Activity
In other news, Director Francis Nelson Shen bought 25,000 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of C$10.23 per share, for a total transaction of C$255,750.00. Corporate insiders own 18.57% of the company's stock.
About Vitalhub
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
